Medtronic continuous glucose monitoring to be reimbursed for eligible people living with type 1 diabetes in Ontario Medical Device Investing
Bloom Health Partners Completes Fiscal Q1 2022 with $5.8M in Revenue and Maintains Guidance for Full Fiscal Year Medical Device Investing
Thermo Fisher Scientific to Present at Cowen's 42nd Annual Healthcare Conference Medical Device Investing
Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program Pharmaceutical Investing
Cloud DX Provides Update on Contracts, Partnerships, and Virtual Care Platform Deployments so Far in 2022 Medical Device Investing
Salix and Colon Cancer Coalition Join Forces for 'Faces of Blue' Story Series to Raise Awareness of Colorectal Cancer Screenings Pharmaceutical Investing
